§Z²ÓMªº¦¨¼ô¨ú¨M©ó½Ñ¦hªºÀô¹Ò¦]¯À¡A¨Ã¨M©wFLªº¦nÃa¡C¦]¬°FLªº°ò¦]³q±`¬O¤£¬¡°Êªº¡A¤@ª½¨ìFL¶}©l¤Àµõ¶¥¬q¤~¬¡ÅD°_¨Ó¡A¦Ó·sªº½u²ÉÅé«hª½¨ìÅnF§Î¦¨«á¤~¶}©l²£¥Í¡C¤£§Q©ó§Z²ÓMªºÀô¹Ò¦]¯À¦³³\¦h¡A¥]¬A¡G°I¦Ñ¡A§ó¦~´Á¡A®ñ¤ÆÀ³¿E¡AªÎD¡A§l·Ï¡A³¤°s©Mºë¯«ºò±i¡A¦Ó¶¯¿E¯Àªº¸É¥R¡A¼f·Vªº¶¼¹¡A¹B°Ê¡AÀç¾i¸É¥R¾¯¡A©M¤ß²z¿Ô°Ó«h³£¬O¦³¯qªº¡C²É½uÅ骺¯à·½²£¥Í¥\¯à¡A§Z±_³Ñ¾l¥\¯à¡A¬V¦âÅé¤ÀÂ÷ªº¯à¤O©MFLªº¦nÃa¡A³£ÀH¦~ÄÖ¼Wªø¦Ó´c¤Æ¡C¦b°I¦Ñ¤p¹«¬ã¨s¤¤¡A²É½uÅ黲§U¦]¤l»²酶Q10°fÂà³o¨ÇÅܤƪº¤j³¡¤À¡C¦b¤HÃþªº¬ã¨s¸gÅç¡AÁöµM¥u¦³¤@Óµu´Áªº¤z¹w©Êªº¤p«¬¬ã¨s¡A¦ý¬O«o¦³¤£¿ù¤§µ²ªG¡C²É½uÅé¥NÁªºÀ£¤O¥i¾ÉP½u²ÉÅéDNA²§±`ªº¥NÀv©Ê¼W¥[¡A§Q¥Î¦¹²{¶H¡A¥i¥H¥H¥ÑF¸²ÓM©Î´þ养¥~F层¤Á¤ù²ÓM¤¤½u²ÉÅéDNA¼Æ¥Ø§@¬°¹w´úFLµÛ§Éªº¥Íª«¼Ð»x¡C¤ß²zÀ£¤O¥i¯à·|³z¹L´î¤Ö§Z±_¦å¬y¨ÑÀ³¦Ó¼vÅT§Z²ÓMªº«~½è¡C´î¤ÖÀ£¤O©Î´î¤Ö¨Åé¹ïÀ£¤Oªº¤ÏÀ³¥i´£°ª¨ü¥¥ªº¦¨¥\²v¡C¥[±j§Z¥À²ÓMªº«~½è¬O¦³®Ä¦a°§C¾ã¿Å骺FLµLªk²£¥Í¬¡²£ªº¤ñ²vªº¤@ÓÃöÁ䪺¦]¤l¡C
«e¨¥
¦b¸ÕºÞÀøµ{¤¤»¤¾É±Æ§Z²£¥Íªº§Z²ÓM¤¤¡A¥u¦³7¢Hªº§Z²ÓM¥i¹F¨ì¬¡²£ªºµ²ªG¡C§Y©l¨Ï¥Îcomprehensive chromosome screening¡]CCS¡^¥þ±¬V¦âÅéÀˬd¡A»{¬°¬V¦âÅ饿±`¤§FL¤]¥u¦³¤T¤À¤§¤GªºFL¹F¨ì¬¡²£¡C
¦b§Z²ÓMªº¦¨¼ô¹Lµ{¤¤¡A²ÓM½èªº¼Æ¶q©M½è¶q¤j´T¼W¥[¡AºÙ¬°²ÓM½èªº¦¨¼ô¡C²ÓM½èªº¦¨¼ô»P§_¡A¥i¨M©w¤@Ó§Z²ÓM²£¥XªºFL¯à§_¹F¨ì¬¡²£ªº¯à¤O¡C§Z²ÓMªº²É½uÅé¬O¤@ÓÃöÁä¦]¤l¡A¦ý³o¤§¶¡«h¨ü¨ì¥ÀÅé¦~¬ö©MÀô¹Ò³\¦hªº¼vÅT¡C
ºë¤l³¡¤À«h¦]ºë¤l»Ýn²£¥Í±j¤jªº¬¡°Ê¤O¡A©Ò¥H©ó¦¨¼ô¹Lµ{¤¤¸À¥h²ÓM½è¡A¦P®É¥¢¥h¨ä¤j³¡¤À¹ï§Ü®ñ¤Æªº¨¾¿m¨t²Î¡A¨Ï±oºë¤l¹ï®ñ¤ÆÀ£¤O«D±`±Ó·P¡C¦¹¥~ºë¤l¤§²ÓM½¤§t¦³°ª¿@«×omega-3ªºàªÕ»Ä¡A¨ä¹ï®ñ¤ÆÀ£¤O«D±`±Ó·P¡C©Ò¥H¤£½×ºë¤l©Î§Z¤l³£¨ü³\¦h¥~¦b¦]¤l¤§¼vÅT¡A¥H¤U¹ï¦¹²{¶H¤§³Ìªñ¤§¬ã¨s°µ¤@¬ÛÃö¤§³ø§i¡C
°ªÄÖ
¦~¬ö¼Wªø¤£¥u¬O¦b»¤¾É±Æ§Z«á¨ú±o§Z¼Æ¸û¤Ö¥~¡A¨ä±o¨ì¤§¥¿±`FLªº¬¡²£²v¤]¸û§C¡C³o«ü¥X°ªÄÖ¤£¥u¹ï²ÓM½è¹ï¬V¦âÅé¤Àµõ¼vÅT¥~¡A¹ï²ÓM½è¥»¨¤§¥\¯à¤]¦³¬Û·í¤§¼vÅT¡C
°£¤F²ÓM½è¤§¼vÅT¥~¡A¤]µo²{ÀH¦~¬ö¼Wªø¡AÂoªw¤¤¶¯©Ê¯Àªº¿@«×¤]ÀH¤§¤U°¡C¤@¯ëª¾¹D¶¯©Ê¯À¡A¥i¼W¥[Âoªw¼Æ¥Ø¤ÎÁû²É²ÓMªº¼W¥Í¤Î´î¤Ö¨ä°h¤Æ¡C´«¨¥¤§¶¯©Ê¯À¥i´£¤É§Z¤l¤§¥\¯à¡C¥t¥~¥Ñ©óÅ餺§Ü®ñ¤Æ¥\¯à¤U°©Ò¥H¤Þ°_®ñ¤ÆÀ£¤O¤§¼W¥[¡A¥ç®e©ö³y¦¨telomeresÁYµu¡A¦Ó®e©ö³y¦¨FL²§±`¤ÎÃh¥¥²v¤U°¡C
¦Ñ¤Æ©ö¨Ïºë¤lDNA²£¥Í¸H¤ù¡A³o¬O¦]¬°®ñ¤ÆÀ£¤O¤§¼W¥[ªº®ÄªG¡A¨Ã¥B¥i§@¬°¨k©Êªº¦~ÄÖ¹ïIVF¦¨¥\ªº¤£§Q¼vÅT¤äì¦]¡C ¦~»´ªº§Z¥À²ÓMªº²ÓM½è¥i¥H×¥¿ºë¤lDNA¤§¸H¤ù¡A¦]¬°¤@Ó¦~»´ªº¤k·fÀɪº§Z¤l©Î¨Ï¥Î®½ÃاZ¤l¥i´î¤Ö°ªÄÖ¨k¤l¹ïÃh¥¥²vªº½ÄÀ»¡C¤£¦Pªº´ú©w©Î´ú©w±ø¥óªº¤£¦P¡A³£·|¼vÅTÀË´úºë¤lDNA¸H¤ùªºÅܤÆ;¦]¦¹¤£½×ÀËÅçµ²ªG¦p¦ó¡AÀ³«Øij©Ò¦³ªº¤H¦b40·³¥H¤W¨k¤l¡A´£°ª§Ü®ñ¤Æ¾¯Äá¤J¶q¡C
ªÎD
ªÎD¬O°ª®ñ¤ÆÀ£¤Oªºª¬ºA¡A¥]¬A§Zªw²Gªºª¬ªp¡A¨Ã¥B·|°§CªºÁ{§ÉÃh¥¥¤ñ²v¡CªÎD¦b¬Y¨Ç®½ÃاZ¤l±µ¨üªÌªº¬ã¨s¼vÅTÅã¥Ü¡AªÎD°£¤F¹ï§Z²ÓM¼vÅT¥~¡A¤]¹ï¤l®c¤º½¤¦³©Ò¼vÅT¡CªÎDÁÙ¼W¥[¬y²£¤ñ²v¡C¤@ÓÅé««ü¼Æ(BMI>35KG/M2) ¦b<32¶g¦²£¾÷·|¤É¬°2¿¡AÂùML¦b<28¶g¤À®Y¤§·ÀI«h¼W¬°¤T¿¡C¥þ¨ª¢¯g«h¬O¦hºØ¥i¯àªº¾÷¨î¤¤¡A³y¦¨¤£¨}µ²§½ªº³Ì¦³¥i¯à¤§®ÄÀ³¡C¹B°Êp¹º¥i¯à¬O³Ì¦³«e³~ªº¤è¦¡¡C¦b¤@¶µ¯f¨Ò¹ï·Ó¬ã¨s¤¤¡A¹B°Ê¹ï©ó¸ÕºÞÀ¦¨àªÎD¤k©Ê¬ã¨sµo²{¡AÁ{§É§³®W²vªº¥i¼W¥[¤T¿¥H¤W¡C
©â·Ï
§l·Ïªº¤k©Ê¦ñ«Q´î¤Ö¤FIVF¨ü¥¥¬ù¤G¤À¤§¤@¡C¬y²£¤ñ²v´X¥G¼W¥[¥|¤À¤§¤@¡C°£§Z±_¥~¤£§Q¼vÅT¤]¥X²{¦b°©¬Ö¡C§l·Ïªº¨k©Ê¦ñ«Q·|´î¤ÖIVF©MM¼ß¤º³æºë¤lª`®g¡]ICSI¡^ªº¦¨¥\¡C¤G¤â·Ï¼vÅTÁöµM¸û¤p¡A¦ý¤´µMÅãµÛ¡C§l·Ï¬OÄY«ªº°ª®ñ¤ÆÀ£¤Oªºª¬ºA¡A©Ò¥H¼W¥[§Ü®ñ¤Æ¾¯ªºÄá¤J¶q¡A¯àÅãµÛ¼W¥[¨º¨ÇµLªk§ÙµÒªÌªºÀ°§U¡C±q§ÙµÒ3-6Ó¤ë«á¦A¶i¦æªºÅé¥~¨üºë¡A²£¥Í¤£¨}ªº¼vÅT¦ü¥G´î®z¡C©Ò¥H3-6Ó¤ë¬O¤@Ó¾A·íªºµ¥«Ý´Á¶¡¡C
°sºë
¤Ò©dÂù¤è³£¦³¶¼°s·|´î¤Ö¤F¸ÕºÞÀ¦¨àªº¦¨¥\²v©M¼W¥[¬y²£¤ñ²v¡CIVF¶g´Á¤§«eÀ³ÄU§i¤Ò©d°±¤î¶¼°s¡C
©@°Ø¦]
ÁöµM¸û¦ªº¬ã¨s¤w¸gªí©ú¡A0-2²@§J/¤Ñªº©@°Ø¦]Äá¤J·|¦³¸û¦nªºIVFµ²ªG¡A¦ý¨âӳ̪ñ¬ã¨sªí©ú¡A©@°Ø¦]¹ïIVFµ²ªG¨S¦³¼vÅT¡C©Ò¥H¦b¨S¦³¶i¤@¨Bªº¼Æ¾Ú¥i°Ñ¦Ò¤§«e¡A¤k©ÊÀ³¸Ó¦Ò¼{¨î©@°Ø¦]ªºÄá¤J¶q¡C
¹B°Ê
¾A«×ªº¹B°Ê¥i§ïµ½°t¤l¥\¯à¤ÎIVFªºµ²ªG¡C¾A«×ªº¹B°Ê³q¹L¼W¥[´`Àô©M²ÓM§Ü®ñ¤Æ¾¯§@¥Î¡A¥i´î¤Ö®ñ¤ÆÀ£¤Oªº¼vÅT¡C¦b«DªÎD¤k©Ê¡A¼@¯P¹B°Ê«h¨ã¦³´î¤ÖIVF¦¨¥\²v¤§±¡§Î¡C¦b¨k¦ñ¡A¨C¶g 5¤p®ÉªºÃM¦Û¦æ¨®¡A·¥¦³¥i¯à¥Ñ©óâé¤Y¥[¼ö¡A¦Ó°§Cºë²G½è¶q¡C
¶¼¹
'ÂÔ·V'ªº¶¼¹¥i´£°ª¥Í¨|¡A¤Ö¬õ¦×©M¹¡©M¯×ªÕ¡A§ó¦h®ü²£«~¡A©M§ó¦hªº¤ôªG©M½µæ¡A¦¹ºØ¶¼¹©¹©¹³QºÙ¬°''¦a¤¤®ü¶¼¹''¡C
§Ü®ñ¤Æ¾¯
¼W¥[§Ü®ñ¤Æ¾¯ªº¶q¥i¥H©è®ø®ñ¤Æª«ªº¤£§Q¼vÅT¡A¨ä¥i¥H³¡¤À¸ÑÄÀ¦b¦a¤¤®ü¶¼¹¤W±±o¨ìªº¦n³B¡C¥Ûºh¡A¥©§J¤O¡A¼ßªG©M¯S¿@©@°Ø¬OÀu¨qªº§Ü®ñ¤Æ¾¯ªº¨Ó·½¡C¤ôªG©M½µæ¤¤§t¦³¤j¶qªº§Ü®ñ¤Æ¾¯¡A¯S§O¦b²iµN¹L«á¶q§ó¼W¥[¡C»®Æ¡A¦pÁ¤¶À¡A§¶µM¡A«¸¡A§t¦³°ª©ó¼ßªG¹F50¿¤§¦hªº§Ü®ñ¤Æ¾¯¡C²§¶Àତ]¬O¨ã¦³§Ü®ñ¤Æ¾¯¡C³\¦h
¸É¥R§Ü®ñ¤Æ¾¯¤¤¡Aºû¥Í¯ÀC¬O³Ì¨ãªí¼x©Mªá¶O³Ì¤Öªº¡C¤@Óºû¥Í¯ÀC©MEªº²Õ¦Xª«¡AÅã¥Ü¨ã¦³°§Cºë¤lDNA¸H¤ù¤ñ²v±q22¦Ü9¢H¡]P <0.001¡^¡C¤£¹LÀ³ÁקKºû¥Í¯ÀE³æ¿W¨Ï¥Î¡A¦]¬°¥¦¤w³QÃì±µ¦Ü·|¼W¥[«e¦C¸¢Àùªº¦UºØì¦]¤§¦º¤`²v¡A¨Ã¥B¤ÞP¦å¤pªO¹ïªü¥q¤ÇªLªº±Ó·P©Ê¼W¥[¡C³o¸Ì©Ò´yzªº¡A¨ä¥L³\¦h±jªº§Ü®ñ¤Æ¾¯¡A¨Ã¨S¦³¹L³o¼Ëªº¦w¥þ°ÝÃD¡CºÑÅÚªéPycnogenol¡A¼ßªG¦h×ôªº¥«°â»s¾¯¡AÅã¥Ü¥X§ïµ½ªººë²G½è¶q¡A´£°ª¶¯©Ê¯À¤ô¥¡C α-²¸¨¯»Ä¡A¼W¥[TAC > 50¢H©M¤@¿§Ö³t¶i¨Bªº°Ê¤O¡C
¥ª±Û¦×ÆPL-Carnitine¡A¤@ºØ®z§Ü®ñ¤Æ¾¯¡A¤wªø´Á¨Ï¥Î©ó¸É¥R¨k©Êªº¥Í¨|¯à¤O¡A¦ý¨ä¤w¸g¯A¤Î¬õ¦×¹ï¤ß¦åºÞ¨t²Îªº¤£§Q¼vÅT¡C¦b¨S¦³¨ä¥L§ó¦nªº²`¤J¬ã¨s¤U¡A¥¦¤£À³¸Ó³Q«Øij¨Ï¥Î¡C
¦b¬ü°ê¡A¦b¹L¥hªº20¦~¸Ì¡A ARTªº¥X¥Í²v¨CÓ¶g´Á¨ÌµM30¢H¨Ã¨S¦³¦¨ªø¡CFL½è¶q¤´µM¬O¤@Ó±j¦³¤Oªº¨M©w¦]¯À¥h¹w´úART¦¨¥\²v¡C±q¥¥°ü¨ì¦X¤l§Î¦¨¡Aª½¨ìFL¦¨ªø¡A¥H¤Î±±¨îFL¦bÅé¥~°ö¾iªº¦¨¥\¦]¤l¡A ¤w¸g³Q´£¥X¥Dn¨Ì¿à¦s¦bM½èªº¦¨¤À¡A¦¹¦¨¤À¤w¸g¦s¦b©óì©l§Z¥À²ÓM©M§Zªw¥Íªø¹Lµ{¤¤Àò±o¡C¦]¦¹¡A
±Æ§Z«á¡A¦¨¼ôªº§Z¥À²ÓM©MÀH«áªºFLªº¥Í¦s¡A´X¥G§¹¥þ¨Ì¿à©ó¥ý«e¦s¦bªº¥ÀÅé
ªºmRNA¡A³J¥Õ½è¡A¤Î¨ä¥L¦]¯À¡A¤×¨ä¬O½u²ÉÅé¡A³o¨Ç¦b§Z²ÓM¥Íªø©M¦¨¼ô¹Lµ{¤¤©Ò²Ö¿nªºª«½è¡C
½u²ÉÅé©M¯à·½¥Í²£
½u²ÉÅé³Q»{¬°±qì®Öµo°_¡A¦¨¬°¤@Ó¯u®Ö¦@¥ÍÅé¡C½u²ÉÅé°ò¦]²Õ¡]½u²ÉÅéDNA¡^¬OÂùÃìÀôª¬ªºDNA¡A¥¦¤£¦P©ó®ÖDNA¡A¤£§t²Õ³J¥Õ¡A¨S¦³¤º§t¤l¡A¨S¦³¥ô¦óDNA×´_酶©M¡A¦]¦¹¡A«Ü®e©ö²£¥Í¬ðÅÜ¡C½u²ÉÅ骺¿ò¶Ç¬O¨Ó¦Û¥À¿Ë¡C¤÷¨t½u²ÉÅé¦b¨üºë«á¤£¤[«á¡A¥Ñ§Z¥À²ÓM³q¹L·»酶Å鰸Ѳ£¥Í²§Åé§]¾½¦Ó®ø¥¢¡C
½u²ÉÅé©ó¥Í²z¾Çªº¤@Ó«n¯S¼x¬O¡A§Z²ÓMªº½u²ÉÅé¼Æ¥Ø¡A±qì©lÂoªw®Éªº§Z²ÓM¶}©lÂX¼W¡A·í®É§t¦³6000Ó½u²ÉÅé¡A¦¨¼ô¤¤´Áªº§Z¡]MII¡^§Z§t30¸U¨ì40¸UÓ½u²ÉÅé©Î§ó¦hªº½u²ÉÅé¡C§Z¥À²ÓM¦¨¼ô¹Lµ{¤¤½u²ÉÅ骺¼Æ¶q¥¨¤jÂX±iI«áªº¥Øªº¬O:§Z¥À²ÓM¥¿¦b¿n·¥·Ç³Æ¼W¥[ªº¯à·½»Ý¨D¡A¥HÀ³¥I¨üºë©M¦´ÁFL¤Àµõµo¨|¡C³o¦ü¥G¬O¦X²zªº¡A¦]¬°½u²ÉÅéDNA½Æ»sªº¯à¤O¬O¦bMIIªº§Z¤º¬O¤£¦s¦bªº¡A¦bFL¶¥¬q§Î¦¨ÅnF¤§«e¤]³£¨S¦³³Q¿E¬¡¡A¡C¦]¦¹¡A§@¬°¤@ÓFL¡A±q§t1Ó²ÓM¨üºë§Z¦Ü§t60-100Ó²ÓMªºÅnF¶¥¬q¡A¨CÓ²ÓM½u²ÉÅ骺¼Æ¶q±N¬O¤£Â_µ}ÄÀ¡C
§Z²ÓMùØ¡A²£¥ÍÁû²É²ÓM(GC)©M§Z¥C²ÓM¡]CCS¡^ªº¤@ºØÁû²É²ÓM¤§«eÅX²ÓM¡A¬O°ß¤@¨Å餺§³®W«á´ÁµLÄ~Äò¤Àµõªº²ÓM¡C¦]¦¹¡A°ªÄÖ°ü¤k¡A¨ä¦bì©l§Zªwªº§Z¥À²ÓM©MÁû²É²ÓM(GC)¡A¤w¸g¼ÉÅS©ó¥Ñ½u²ÉÅé©I§l¹B°Ê²£¥Í¤§§C¶q¬¡©Ê®ñ´X¤Q¦~¡A¦]¦Ó³y¦¨½u²ÉÅé©M½u²ÉÅéDNAªº²Ö¿n·l¶Ë¡C§Z¥À²ÓM¤º½u²ÉÅ鬡©Ê¡A³q±`ÀHµÛ¤@Ó¤k¤Hªº¦~ÄÖ³v¨B¤U°¡C¦¹¥~¡A¤@Ó§Z¥À²ÓM¤ºªº½u²ÉÅ骺¼Æ¥Ø¡Aª½±µ©M¨ä¨üºëªº¥i¯à©Ê¡A¥H¤ÎFL´Ó¤J«eªºµo®i¦³¬ÛÃö©Ê¡C¦¹¥~¡A´¿¸g¸g¾úIVF¥¢±Ñªº¸gÅ窺°ü¤k¡A¨ä§Z¥À²ÓM¤ºªº½u²ÉÅé¥\¯à©¹©¹¬O¦³©Ò¤£¨¬ªº¡C
»²酶Q10
°£¤F¦b½u²ÉÅ骺§ïÅÜ¡A¤]µo²{¦Ñ¦~¤k©Êªº§Z¥À²ÓM©P³ò¥]³ò§ó¤ÖªºÁû²É²ÓM(CC)¡A¥Dn¦]¬°Áû²É²ÓM¦º¤`ªº³t²v¼W¥[¡C³oªí©ú¦b¦Ñ¦~¤k©Êªº§Z¥À²ÓM¡A±Á{¥Ñ©óÁû²É²ÓM(CC)Àç¾i¦]¤l»s³y¤£¨¬©Òl¥Íªº¥NÁÂÀ£¤O¡A¨ä¤¤¤§¤@¦]¤l¬O»²酶Q10¡C¦³½ìªº¬O¡A»²酶Q10ªºªvÀø¾ÉP¨CÓ§Z¥À²ÓM©P³òCCªº¼Æ¥Ø¤É°ª¡Aªí©úªvÀø®ÄªG¤£¬O§½©ó¥Í´Þ²ÓM¡C¥Ñ©ó»²酶Q10ªvÀø¡A¨Ï±oFL½è¶q©M°ªÄÖ²£°üªºÁc´Þ¯à¤O¦nÂà¡C¦]¦¹»²酶Qªº¦X¦¨°ò¦]¡A¦b¦~»´CC»P¦Ñ¤k©ÊCCªºªí²{¡A¥²¶·³Q¶i¤@¨B¶i¦æ¬ã¨s¡C
¦Ñªº§Z²ÓM¤¤Æ[¹î¨ìªº¯Ê³´¡A¥]¬A´î¤ÖATPªº²£¥Í©M½u²ÉÅ鬡©Ê¸û®t¡C³o¨Ç¦Ñ¤Æ§Z²ÓMªº±¡ªp¡A¦b°Êª«¹êÅ礤¡A¥i¥Ñ¦~»´§Z²ÓM¡A³æ¿W°§C¨äCoQ¥Í²£¨Ó§Î¦¨¦¹¨Ç¦Ñ¤Æ§Z²ÓMªº±¡ªp¡C¦³½ìªº¬O¡A³o¨Ç±¡§Î¥ç¥i¥Ñ»²酶Q10ªº¸É¥R¨Ó¶i¦æ°fÂà¡C©Ò¥H¦b°Êª«¹êÅ礤¡A¸É¥R»²酶Q10¥i°fÂà¦Ñ¤Æ§Z²ÓM¤§ATPªº²£¥Í¸û¤Ö©M½u²ÉÅ鬡©Ê¸û®t¤§±¡§Î¡C
§Z¥À²ÓMª`®g°·±d²É½uÅé
2004¦~¡ATilly¹êÅç«Çµo²{ªº¦ÛÅé¨Ó·½ªº¥Í´Þ¨t½u²ÉÅé¡C³o¨Ç²É½uÅé³Qµo²{¦b¯Ê¦å©Êªº§Z±_¥~¥Ö¼h¤ºªºegg precursor cells (PCs)¸Ì¡C±q°ªÄÖ¤k¤H¦Û¤vªº§Z¤lªºPCs¤ÀÂ÷¥Xªº½u²ÉÅé¥X²{Ãþ¦ü¦~»´§Z²ÓM²É½uÅé¡A¨Ã¥i¥H§@¬°²É½uÅ骺¦ÛÅé¨Ó·½¡A¥Î©óª`¤J¯Ê·lªº§Z²ÓM¡A±q¦ÓÁקK¤F¥Ñ®½§U§Z²ÓM²É½uÅéª`¤J©Ò²£¥Íªº°ÝÃD¡C
´£°ª§Z²ÓM©MFL²É½uÅé¯à·½¥Í²£¡A¥i¯à§ïµ½¥Í´Þ¹w«á¡A©ÎFLµo¨|¤£¨}©M¤ÏÎ`§³®W¥¢±Ñµ¥°I¦Ñ²£¥Íªº°ÝÃD¡C²É½uÅéÀç¾i¯À¡A¦p»²酶Q10¡A¨Ã±q§Z²ÓMPCsÀò±oªº¦ÛÅé°·±dªº²É½uÅéª`®g¡A³o¨âºØ¤èªk¥i¯à¬°´£°ª°ªÄÖ¤k¤H¶i¦æARTªº¬¡²£²v¡C
½u²ÉÅé§@¬°¯à¶qÀ£¤O·P¨ü¾¹
FLªºµo¨|¬O¨Ì¿à©ó§Z²ÓM¦¨¼ô¹Lµ{¤¤¯à¶q¿n²Ö¡C¨äµ²ªG¬O¡A¦b¬Y¨Ç±¡ªp¤U¡A½u²ÉÅéDNA½Æ»s¼Æ¶q¥i¥H¬O¤@Óµ²ªG¡A¦Ó¤£¬O§Z¥À²ÓMªº¯à¶qª¬ºAªº®Ú¥»ì¦]¡C³o¬O³q¹LÆ[¹îµo²{¡A½u²ÉÅé¥\¯à»Ùê¡A±`±`»PÅãµÛ½u²ÉÅé¹L«×¼W´Þ¦³¬ÛÃöÁp¡C¦]¦¹''½u²ÉÅéµ~¢''ªºP¯f§@¥Î¡A¾ÉP½u²ÉÅ骺¥Í²£ÅãµÛ¼W¥[¡C¦³¨âÓ¹êÅç«Ç¬ã¨s¡A¤w¸g¿W¥ßÃÒ©ú¤F¡A¦b°ª«þ¨©¼ÆmtDNA¤§¾ã¿ÅéFL¡A¨äFL¦s¬¡²v¤Î´Ó¤J¼ç¤O¬O¤U°ªº¡C
À£¤O¼vÅTªº²z½×
¨Ï¥Î¨å«¬ªº'¾Ô°«©Î°k¶]'¤ÏÀ³²z½×¡A¨Ó¸ÑÄÀÀ£¤O¤£§Q©óIVFµ²§½¬O¤£¿ùªº²z½×¡C¦b¨üÀ£¤O¤U¡A¦å²G±q'«D¥»½è'¾¹©x¡A¦p§Z±_Âಾ¨ì¤ßŦ¡B¤j¸£©M¦Ù¦×¡A¥H³B²z«Â¯Ù¡C Facchinetti µ¥¤Hµo²{¡A·í±¹ïºò±i¨ë¿E®É¡A¦bµÎ±i´Á¦åÀ£¤j´T¤W¤É¤§§Y±N±µ¨üÅé¥~¨üºë¡]IVF¡^¤§°ü¤k¡A¥i¹w´ú¨äÃh¥¥ªº¾÷·|¸û§C¡C
µ²½×
§Ṳ́w¸g´£¥X¤@¨Ç±¹¬I¡A³o±N¼W¥[¾ã¿ÅéFL²£¥Í¬¡²£ªº¤ñ¨Ò¡C¹ï©ó¨k©Ê¦ñ«Q¡Aomega-3 Fas©M§Ü®ñ¤Æ¾¯¬O³ÌÃöÁ䪺¡C¹ï©ó¤k©Ê¦ñ«Q¡A´î¤ÖÀ£¤O»P¤HÅ骺¹ïÀ£¤Oªº¤ÏÀ³¡A¹B°Ê©MªÎD°ü¤kªºÅé«´î»´¡AÁקK¼@¯P¹B°Êªº«DªÎD°ü¤k¡A¶i¦æ IVF¤§«e3-6Ó¤ë§ÙµÒ¡A¨ÃÁקK°sºë³£¬O«D±`«nªº¡C¾A«×¹B°Ê©M𷪺¶¼¹¤]±N¬O¦³¯qªº¡C°w¹ï¦]¬°¦Ñ¤Æ²£¥Íªº®ñ¤ÆÀ£¤O¡AªÎD¡Aºë²G½è¶q®t¡A°§Cªº§Z²ÓM©MFL½è¶q¡A¼W¥[§Ü®ñ¤Æ¾¯ªºÄá¤J¶q¬O¨k¤kÂù¤è¡A¯S§O¬O¨º¨Ç±µªñ©Î40·³¥H¤W°t°¸ªº¨}¦nªº±`³W±¹¬I¡C©Ò¦³³o¨Ç±¹¬Iªº´yz¤]§ïµ½¦åºÞ©M«k°_¥\¯à¡A¨Ã±N¹ïªø´Áªº°·±d²£¥Í¦³§Qªº¼vÅT¡C¸û·sªº¤èªk¡A¦p»²酶Q10¡A®Ú¾Ú«D¤H©M¦³ªº¤HÃþ¬ã¨s¡A¬O«D±`¦³À°¦£ªº¡C¦]¬°¤j¦h¼Æ³o¨Ç¤z¹w¬O¥Ñ¼Æ¶q¦³ªº¬ã¨s©Ò¤ä«ù¡A¶i¤@¨BªºÂùª¼©MÀH¾÷¸ÕÅç³£n¦A¶i¦æ¡A¥H¶i¤@¨BÃÒ¹ê¨ä®ÄªG¡C
REFERENCES
1. Li R, Albertini DF. The road to maturation: somatic cell interaction and selforganization of the mammalian oocyte. Nat Rev Mol Cell Biol 2013;14:
141 –52.
2. Dumesic DA, Meldrum DR, Katz-Jaffe MG, Krisher RL, Schoolcraft WB.
Oocyte environment: follicular fluid and cumulus cells are critical for oocyte
health. Fertil Steril 2015;103:303–16.
3. Patrizio P, Sakkas D. From oocyte to baby: a clinical evaluation of the biological efficiency of in vitro fertilization. Fertil Steril 2009;91:1061 –6.
4. Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al.
The nature of aneuploidy with increasing age of the female partner: a review
of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014;101:656–63. e1 .
5. Ben-Meir A, Burstein E, Borrego-Alvarez A, Chong J, Wong E, Yavorska T,
et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility
during reproductive aging. Aging Cell 2015.
6. Meldrum DR, Chang RJ, Giudice LC, Balasch J, Barbieri RL. Role of
decreased androgens in the ovarian response to stimulation in older
women. Fertil Steril 2013;99:5–11 .
7. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in
adult females: changes with age, menopause, and oophorectomy. J Clin
Endocrinol Metab 2005;90:3847–53.
8. Barbieri RL, Sluss PM, Powers RD, McShane PM, Vitonis A, Ginsburg E, et al.
Association of body mass index, age, and cigarette smoking with serum
testosterone levels in cycling women undergoing in vitro fertilization. Fertil
Steril 2005;83:302–8.
9. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;
101:2622–9.
10. Tartagni M, Cicinelli MV, Baldini D, Tartagni MV, Alrasheed H,
DeSalvia MA, et al. Dehydroepiandrosterone decreases the age-related
decline of the in vitro fertilization outcome in women younger than 40
years old. Reprod Biol Endocrinol 2015;13:18.
11. Kim CH, Howles CM, Lee HA. The effect of transdermal testosterone gel
pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril 2011;95:679–83.
12. Fabregues F, Penarrubia J, Creus M, Manau D, Casals G, Carmona F, et al.
Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod 2009;24:349–59.
13. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic
mechanisms, functional effects, and pathological considerations. Am J
Physiol Regul Integr Comp Physiol 2007;292:R18–36.
14. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, et al. Decline in
transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 2004;
101:3381 –6.
15. Tatone C, Amicarelli F. The aging ovary—the poor granulosa cells. Fertil
Steril 2013;99:12–7.
16. Kalmbach KH, Fontes Antunes DM, Dracxler RC, Knier TW, Seth-Smith ML,
Wang F, et al. Telomeres and human reproduction. Fertil Steril 2013;99:
23–9.
556 VOL. 105 NO. 3 / MARCH 2016
VIEWS AND REVIEWS
Downloaded from ClinicalKey.com at Chi Mei Foundation Hospital April 01, 2016.
For personal use only. No other uses without permission. Copyright ©2016. Elsevier Inc. All rights reserved.
17. Humm KC, Sakkas D. Role of increased male age in IVF and egg donation:
is sperm DNA fragmentation responsible? Fertil Steril 2013;99:30–6.
18. Mahfouz R, Sharma R, Thiyagarajan A, Kale V, Gupta S, Sabanegh E, et al.
Semen characteristics and sperm DNA fragmentation in infertile men with
low and high levels of seminal reactive oxygen species. Fertil Steril 2010;94:
2141 –6.
19. de La Rochebrochard E, de Mouzon J, Thepot F, Thonneau P. French National IVFRA. Fathers over 40 and increased failure to conceive: the lessons
of in vitro fertilization in France. Fertil Steril 2006;85:1420–4
20. Lathi RB, Liebert CA, Brookfield KF, Taylor JA, vom Saal FS, Fujimoto VY,
et al. Conjugated bisphenol A in maternal serum in relation to miscarriage
risk. Fertil Steril 2014;102:123–8.
21. Knez J, Kranvogl R, Breznik BP, Voncina E, Vlaisavljevic V. Are urinary bisphenol A levels in men related to semen quality and embryo development
after medically assisted reproduction? Fertil Steril 2014;101:215–21. e5.
22.Vaamonde D, da Silva-Grigoletto ME, Garcia-Manso JM, Barrera N, Vaamonde-Lemos R. Physically active men show better semen parameters
and hormone values than sedentary men. Eur J Appl Physiol 2012;112:
3267–73.
23. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and
follicular renewal in the postnatal mammalian ovary. Nature 2004;428:
145–50.
24. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL. Oocyte formation
by mitotically active germ cells purified from ovaries of reproductive-age
women. Nat Med 2012;18:413–21 .
25. Barritt JA, Brenner CA, Malter HE, Cohen J. Mitochondria in human
offspring derived from ooplasmic transplantation. Hum Reprod 2001;16:
513–6